Pay in 4 interest-free payments of $5.76 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Cost-effectiveness analysis A 2025 cost-effectiveness study published in PubMed found that tirzepatide was dominant over liraglutide from a UK healthcare perspective, meaning it produced both better outcomes and lower costs
A novel ferroptosis related gene signature for prognosis prediction in patients with colon cancer
This study is expected to enroll ~13,000 patients suffering from obesity
Call (954) 561-3175 or contact us online
A 3D-printed hydrogel patch coated with VEGF and modified by tetrapodal zinc oxide particles has been developed to achieve controlled release of VEGF and regulate angiogenesis during wound healing (Siebert et al., 2021)
Clin Immunol (2013) 149(3):55665
US$ 22.02
US$ 27.09
US$ 23.03
US$ 22.88
US$ 27.45
US$ 28.11
